These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38087188)

  • 41. Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism.
    Asakawa M; Takagi N; Hamada D; Yamasaki Y; Takaku Y; Kawada M; Murata T; Katsuta H
    Intern Med; 2023 Oct; 62(20):2981-2988. PubMed ID: 36858518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidative stress in patients affected by primary aldosteronism.
    Petramala L; Pignatelli P; Carnevale R; Zinnamosca L; Marinelli C; Settevendemmie A; Concistrè A; Tonnarini G; De Toma G; Violi F; Letizia C
    J Hypertens; 2014 Oct; 32(10):2022-9; discussion 2029. PubMed ID: 24979305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary aldosteronism: management issues.
    Young WF
    Ann N Y Acad Sci; 2002 Sep; 970():61-76. PubMed ID: 12381542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment.
    Velema M; Dekkers T; Hermus A; Timmers H; Lenders J; Groenewoud H; Schultze Kool L; Langenhuijsen J; Prejbisz A; van der Wilt GJ; Deinum J;
    J Clin Endocrinol Metab; 2018 Jan; 103(1):16-24. PubMed ID: 29099925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
    Stimpel M; Ivens K; Volkmann HP; Wambach G; Kaufmann W
    Klin Wochenschr; 1989 Feb; 67(4):248-52. PubMed ID: 2648061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic alterations in patients with primary aldosteronism.
    Takeda Y
    Hypertens Res; 2001 Sep; 24(5):469-74. PubMed ID: 11675938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry.
    Araujo-Castro M; Paja Fano M; González-Boillos M; Pascual-Corrales E; Martín Rojas-Marcos P; García-Cano A; Ruiz-Sanchez JG; Vicente A; Gómez-Hoyos E; Casterás A; Puig-Pérez A; García Sanz I; Recasens M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo CM; Manjón-Miguélez L; Rebollo Román A; Robles Lázaro C; María Recio J; Morales-Ruiz M; Calatayud M; Jiménez López N; Meneses D; Sampedro Nuñez M; Mena Ribas E; Sanmartín Sánchez A; Gonzalvo Diaz C; Lamas C; Castillo Tous MD; Serrano J; Michalopoulou T; Tenés Rodrigo S; Roa Chamorro R; Jaén Aguila F; Moya Mateo EM; Gutiérrez-Medina S; Hanzu FA; Parra Ramírez P
    J Hypertens; 2024 Oct; 42(10):1805-1812. PubMed ID: 39051487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
    Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
    Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time-Dependent Risk of Atrial Fibrillation in Patients With Primary Aldosteronism After Medical or Surgical Treatment Initiation.
    Kim KJ; Hong N; Yu MH; Lee H; Lee S; Lim JS; Rhee Y
    Hypertension; 2021 Jun; 77(6):1964-1973. PubMed ID: 33866798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of the medical treatment of primary aldosteronism.
    Lim PO; Young WF; MacDonald TM
    J Hypertens; 2001 Mar; 19(3):353-61. PubMed ID: 11288803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
    Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP
    Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The long-term administration of dexamethasone for the differentiation of the 4 types of hyperaldosteronism].
    Watanabe Y; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1995 Mar; 71(2):149-66. PubMed ID: 7750627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Have main types of primary aldosteronism different phenotype?
    Somlóová Z; Indra T; Rosa J; Petrák O; Strauch B; Zelinka T; Holaj R; Widimský J
    Physiol Res; 2012; 61(4):431-6. PubMed ID: 22670702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The risk factors for hepatic steatosis in patients with primary aldosteronism.
    Shibayama Y; Wada N; Baba S; Obara S; Sakai H; Usubuchi H; Terae S; Nakamura A; Atsumi T
    Endocr J; 2020 Jun; 67(6):623-629. PubMed ID: 32213734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
    Tezuka Y; Turcu AF
    Endocr Pract; 2020 Dec; 26(12):1416-1424. PubMed ID: 33471733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of primary aldosteronism: its complications and their outcomes after treatment.
    Giacchetti G; Turchi F; Boscaro M; Ronconi V
    Curr Vasc Pharmacol; 2009 Apr; 7(2):244-49. PubMed ID: 19356005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma Aldosterone After Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary Aldosteronism.
    Wu CH; Wu V; Yang YW; Lin YH; Yang SY; Lin PC; Chang CC; Tsai YC; Wang SM;
    Am J Hypertens; 2019 Oct; 32(11):1066-1074. PubMed ID: 31216359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term results of surgical and conservative treatment of patients with primary aldosteronism.
    Horký K; Widimský J; Hradec E; Gregorová I; Hradec M
    Exp Clin Endocrinol; 1987 Dec; 90(3):337-46. PubMed ID: 3450533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism.
    Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chung SD;
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):838-846. PubMed ID: 33261310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.